Carmine Zoccali

CNR-IBIM Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Arteriosa , Ospedali Riuniti , Italy

Carmine Zoccali

Academic positions:
- Director of the Division of Nephrology, Hypertension and Renal Transplantation
- Research Group Leader of the "Clinical Epidemiology of Renal Diseases and Hypertension Unit" of the National Research Council- IBIM at Riuniti Hospital, Reggio Calabria
- Professor of Nephrology at the Postgraduate Schools of Nephrology, Universities of Palermo, Messina and Catania Sicily, Italy

All industry positions (in last five years):
None declared

Research interests:
Dr. Zoccali's research interests cover hypertension, cardiovascular complications in chronic renal failure, renal disease progression and the epidemiology of chronic renal failure.

Any other information:
He has contributed over 500 publications on these areas to the scientific literature, including 258 papers in international peer-reviewed journals. Chief Editor of Nephrology, Dialysis and Transplantation-Educational and Subject Editor (hypertension) of Nephrology, Dialysis and Transplantation, he holds editorial positions on several national and international journals including J Am Soc Nephrology and Kidney International. He was Associated Editor of the Am J Kidney Dis. (2004-2006) and Deputy Chief Editor of Journal of Nephrology (2000-2006).

Dr. Zoccali is President of the Italian Society of Nephrology and Chairman of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry of Dialysis and Transplantation. A member of 10 national and international societies of Nephrology and Hypertension, he received international awards by the Am Kidney Foundation and the Borelli Foundation.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Dialysis & Renal Transplantation (since 06 June 2006)

Links

http://www.giofil.it/offline/440238B.HTM

All recent recommendations

• 3.0
  Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study.
  Recommended by Carmine Zoccali
  
• 3.0
  Age as a modifiable risk factor for cardiovascular disease.
  Recommended by Carmine Zoccali
  
• 6.0
  SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
  Recommended by Carmine Zoccali
  
• 6.0
  Association between multidisciplinary care and survival for elderly patients with chronic kidney disease.
  Recommended by Carmine Zoccali
  
• 6.0
  Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
  Recommended by Carmine Zoccali
  
• 3.0
  Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
  Recommended by Carmine Zoccali
  
• 3.0
  Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study.
  Recommended by Carmine Zoccali
  
• 6.0
  Disruption of methylarginine metabolism impairs vascular homeostasis.
  Recommended by Carmine Zoccali
  
• 3.0
  A wearable haemodialysis device for patients with end-stage renal failure: a pilot study.
  Recommended by Carmine Zoccali
  
• 6.0
  Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
  Recommended by Carmine Zoccali
  
• 3.0
  Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?
  Recommended by Carmine Zoccali
  
• 8.0
  Prevalence of chronic kidney disease in the United States.
  Recommended by Ernie Esquivel, Carmine Zoccali
  
• 3.0
  Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
  Recommended by Carmine Zoccali
  
• 6.0
  Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
  Recommended by Carmine Zoccali
  
• 6.0
  Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.
  Recommended by Carmine Zoccali
  
• 6.0
  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
  Recommended by Carmine Zoccali
  
• 6.0
  Cystatin C as a risk factor for outcomes in chronic kidney disease.
  Recommended by Carmine Zoccali
  
• 3.0
  Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom.
  Recommended by Carmine Zoccali
  
• 3.0
  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.
  Recommended by Carmine Zoccali
  
• 3.0
  Low glomerular filtration in the population: prevalence, associated disorders, and awareness.
  Recommended by Carmine Zoccali
  
• 6.0
  Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
  Recommended by Carmine Zoccali